Abstract
Resistance of influenza A viruses to neuraminidase inhibitors can arise through mutations in the neuraminidase (NA) gene. We show here that a Q136K mutation in the NA of the 2009 pandemic H1N1 virus confers a high degree of resistance to zanamivir. Resistance is accompanied by reduced numbers of NA molecules in viral particles and reduced intrinsic enzymatic activity of mutant NA. Interestingly, the Q136K mutation strongly impairs viral fitness in the guinea pig transmission model.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Substitution
-
Animals
-
Antiviral Agents / pharmacology*
-
Disease Models, Animal
-
Drug Resistance, Viral*
-
Guinea Pigs
-
Influenza A Virus, H1N1 Subtype / drug effects*
-
Influenza A Virus, H1N1 Subtype / genetics
-
Influenza A Virus, H1N1 Subtype / pathogenicity
-
Influenza A Virus, H1N1 Subtype / physiology*
-
Molecular Sequence Data
-
Mutant Proteins / genetics
-
Mutant Proteins / metabolism
-
Mutation, Missense
-
Neuraminidase / genetics*
-
Neuraminidase / metabolism
-
Orthomyxoviridae Infections / transmission
-
Orthomyxoviridae Infections / virology
-
RNA, Viral / genetics
-
Sequence Analysis, DNA
-
Viral Proteins / genetics*
-
Viral Proteins / metabolism
-
Virulence
-
Virulence Factors / genetics*
-
Virulence Factors / metabolism
-
Zanamivir / pharmacology*
Substances
-
Antiviral Agents
-
Mutant Proteins
-
RNA, Viral
-
Viral Proteins
-
Virulence Factors
-
NA protein, influenza A virus
-
Neuraminidase
-
Zanamivir
Associated data
-
GENBANK/HQ111361
-
GENBANK/HQ111362
-
GENBANK/HQ111363
-
GENBANK/HQ111364
-
GENBANK/HQ111365
-
GENBANK/HQ111366
-
GENBANK/HQ111367
-
GENBANK/HQ111368